Circadia Technologies

Circadia Technologies develops FDA-cleared continuous monitoring and predictive analytics solutions for senior care facilities and payers. The company manufactures the Circadia C200, a contactless radar-based early detection device that monitors heart rate, respiratory rate, bed exits, and patient motion. The C200 integrates with Circadia's proprietary Clinical Intelligence Platform, which uses machine learning and AI to generate real-time alerts and daily risk reports to prevent rehospitalizations and identify fall risks. The platform is marketed as a predictive care solution for skilled nursing facilities (SNFs), assisted living, and other senior care settings. Circadia's technology is Medicare-reimbursable and deployed across major healthcare providers. The company reports monitoring 30,000+ patients daily, with demonstrated outcomes including 30% reduction in rehospitalizations after 12 months and 78% sensitivity for detecting preventable hospitalizations. The C200 is FDA-cleared for its specified vital sign and motion detection capabilities. Circadia serves a network of senior care operators, health systems, and payers with contracted ROI models ($316K yearly per 100-bed SNF for providers; $864K for payers). The company combines hardware (radar-based sensor), software (analytics platform), and clinical services to deliver comprehensive preventive care solutions.